Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Mol Psychiatry

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    May 2017
  1. WEINSTEIN JJ, van de Giessen E, Rosengard RJ, Xu X, et al
    PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  2. MOBERGET T, Doan NT, Alnaes D, Kaufmann T, et al
    Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls.
    Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  3. BIRNBAUM R, Jaffe AE, Chen Q, Shin JH, et al
    Investigating the neuroimmunogenic architecture of schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  4. TAO R, Davis KN, Li C, Shin JH, et al
    GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  5. DEMICHELE-SWEET MAA, Weamer EA, Klei L, Vrana DT, et al
    Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    Mol Psychiatry. 2017 May 2. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    April 2017
  6. DUNCAN LE, Ratanatharathorn A, Aiello AE, Almli LM, et al
    Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.
    Mol Psychiatry. 2017 Apr 25. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  7. HADAR R, Bikovski L, Soto-Montenegro ML, Schimke J, et al
    Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia.
    Mol Psychiatry. 2017 Apr 4. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    March 2017
  8. NOTTER T, Meyer U
    Microglia and schizophrenia: where next?
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format    


  9. PARKER KL, Kim YC, Kelley RM, Nessler AJ, et al
    Delta-frequency stimulation of cerebellar projections can compensate for schizophrenia-related medial frontal dysfunction.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  10. LYALL AE, Pasternak O, Robinson DG, Newell D, et al
    Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  11. DEVOR A, Andreassen OA, Wang Y, Maki-Marttunen T, et al
    Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  12. STEULLET P, Cabungcal JH, Coyle J, Didriksen M, et al
    Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia.
    Mol Psychiatry. 2017 Mar 21. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  13. CHANG H, Xiao X, Li M
    The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  14. PAGE SC, Hamersky GR, Gallo RA, Rannals MD, et al
    The schizophrenia- and autism-associated gene, transcription factor 4 regulates the columnar distribution of layer 2/3 prefrontal pyramidal neurons in an activity-dependent manner.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  15. ROFFMAN JL, Petruzzi LJ, Tanner AS, Brown HE, et al
    Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  16. ORHAN F, Fatouros-Bergman H, Goiny M, Malmqvist A, et al
    CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    February 2017
  17. LEE PH, Baker JT, Holmes AJ, Jahanshad N, et al
    Partitioning heritability analysis reveals a shared genetic basis of brain anatomy and schizophrenia.
    Mol Psychiatry. 2017 Feb 21. doi: 10.1038/mp.2017.
    PubMed     Text format    


  18. COLLSTE K, Plaven-Sigray P, Fatouros-Bergman H, Victorsson P, et al
    Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28.
    Mol Psychiatry. 2017 Feb 14. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  19. LEE M, Sehatpour P, Hoptman MJ, Lakatos P, et al
    Neural mechanisms of mismatch negativity dysfunction in schizophrenia.
    Mol Psychiatry. 2017 Feb 7. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    January 2017
  20. MITCHELL AC, Javidfar B, Pothula V, Ibi D, et al
    MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.
    Mol Psychiatry. 2017 Jan 24. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  21. ROALF DR, Nanga RP, Rupert PE, Hariharan H, et al
    Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum.
    Mol Psychiatry. 2017 Jan 24. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  22. VAUCHER J, Keating BJ, Lasserre AM, Gan W, et al
    Cannabis use and risk of schizophrenia: a Mendelian randomization study.
    Mol Psychiatry. 2017 Jan 24. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  23. NOTTER T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, et al
    Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
    Mol Psychiatry. 2017 Jan 17. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  24. QIN XY, Wu HT, Cao C, Loh YP, et al
    A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia.
    Mol Psychiatry. 2017 Jan 10. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  25. ST POURCAIN B, Robinson EB, Anttila V, Sullivan BB, et al
    ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties.
    Mol Psychiatry. 2017 Jan 3. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    December 2016
  26. CLIFTON NE, Pocklington AJ, Scholz B, Rees E, et al
    Schizophrenia copy number variants and associative learning.
    Mol Psychiatry. 2016 Dec 13. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  27. YU H, Yan H, Li J, Li Z, et al
    Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population.
    Mol Psychiatry. 2016 Dec 6. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    November 2016
  28. BADER V, Trossbach SV, Prikulis I, Godsave SF, et al
    Misassembly of non-mutant full-length Disrupted-in-Schizophrenia 1 protein is induced by dopamine in vitro and in vivo.
    Mol Psychiatry. 2016;21:1487.
    PubMed     Text format    


  29. SCARR E, Udawela M, Thomas EA, Dean B, et al
    Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor.
    Mol Psychiatry. 2016 Nov 1. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    October 2016
  30. DELEVICH K, Abi-Dargham A, Hall J, Sawa A, et al
    Studying schizophrenia in the post-genomic era: perspectives from the 2016 summer Banbury Workshop at Cold Spring Harbor Laboratory.
    Mol Psychiatry. 2016 Oct 25. doi: 10.1038/mp.2016.
    PubMed     Text format    


  31. XU J, Hartley BJ, Kurup P, Phillips A, et al
    Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models.
    Mol Psychiatry. 2016 Oct 18. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  32. LEE PH, Baker JT, Holmes AJ, Jahanshad N, et al
    Partitioning heritability analysis reveals a shared genetic basis of brain anatomy and schizophrenia.
    Mol Psychiatry. 2016 Oct 11. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  33. HASAN A, Wobrock T, Guse B, Langguth B, et al
    Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia.
    Mol Psychiatry. 2016 Oct 11. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  34. HOLMES SE, Hinz R, Drake RJ, Gregory CJ, et al
    In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [11C](R)-PK11195 positron emission tomography study.
    Mol Psychiatry. 2016 Oct 4. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    September 2016
  35. STEDEHOUDER J, Kushner SA
    Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia.
    Mol Psychiatry. 2016 Sep 20. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  36. NIWA M, Cash-Padgett T, Kubo KI, Saito A, et al
    DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1.
    Mol Psychiatry. 2016 Sep 6. doi: 10.1038/mp.2016.
    PubMed     Text format    


    August 2016
  37. DONEGAN JJ, Tyson JA, Branch SY, Beckstead MJ, et al
    Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent model.
    Mol Psychiatry. 2016 Aug 2. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    July 2016
  38. KIM MJ, Biag J, Fass DM, Lewis MC, et al
    Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity.
    Mol Psychiatry. 2016 Jul 26. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    June 2016
  39. TREPANIER MO, Hopperton KE, Mizrahi R, Mechawar N, et al
    Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review.
    Mol Psychiatry. 2016 Jun 7. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    May 2016
  40. KUSHIMA I, Aleksic B, Nakatochi M, Shimamura T, et al
    High-resolution copy number variation analysis of schizophrenia in Japan.
    Mol Psychiatry. 2016 May 31. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  41. JENKINS AK, Paterson C, Wang Y, Hyde TM, et al
    Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging.
    Mol Psychiatry. 2016;21:701-6.
    PubMed     Text format     Abstract available


    April 2016
  42. KEBIR O, Chaumette B, Rivollier F, Miozzo F, et al
    Methylomic changes during conversion to psychosis.
    Mol Psychiatry. 2016 Apr 26. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    March 2016
  43. HOMANN OR, Misura K, Lamas E, Sandrock RW, et al
    Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness.
    Mol Psychiatry. 2016 Mar 22. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    February 2016
  44. HO NF, Iglesias JE, Sum MY, Kuswanto CN, et al
    Progression from selective to general involvement of hippocampal subfields in schizophrenia.
    Mol Psychiatry. 2016 Feb 23. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  45. GOLDSMITH DR, Rapaport MH, Miller BJ
    A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Mol Psychiatry. 2016 Feb 23. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  46. CARR GV, Chen J, Yang F, Ren M, et al
    KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia.
    Mol Psychiatry. 2016 Feb 9. doi: 10.1038/mp.2015.
    PubMed     Text format     Abstract available


  47. MCCLATCHY DB, Savas JN, Martinez-Bartolome S, Park SK, et al
    Global quantitative analysis of phosphorylation underlying phencyclidine signaling and sensorimotor gating in the prefrontal cortex.
    Mol Psychiatry. 2016;21:205-15.
    PubMed     Text format     Abstract available


  48. LI J, Cai T, Jiang Y, Chen H, et al
    Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
    Mol Psychiatry. 2016;21:290-7.
    PubMed     Text format     Abstract available


  49. LU C, Chen Q, Zhou T, Bozic D, et al
    Micro-electrode array recordings reveal reductions in both excitation and inhibition in cultured cortical neuron networks lacking Shank3.
    Mol Psychiatry. 2016;21:159-68.
    PubMed     Text format     Abstract available


  50. ROWLAND LM, Krause BW, Wijtenburg SA, McMahon RP, et al
    Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study.
    Mol Psychiatry. 2016;21:198-204.
    PubMed     Text format     Abstract available


  51. KENDLER KS
    The transformation of American psychiatric nosology at the dawn of the twentieth century.
    Mol Psychiatry. 2016;21:152-8.
    PubMed     Text format     Abstract available


    January 2016
  52. OKADA N, Fukunaga M, Yamashita F, Koshiyama D, et al
    Abnormal asymmetries in subcortical brain volume in schizophrenia.
    Mol Psychiatry. 2016 Jan 19. doi: 10.1038/mp.2015.
    PubMed     Text format     Abstract available


  53. TROSSBACH SV, Bader V, Hecher L, Pum ME, et al
    Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits.
    Mol Psychiatry. 2016 Jan 12. doi: 10.1038/mp.2015.
    PubMed     Text format     Abstract available


  54. GUAN L, Wang Q, Wang L, Wu B, et al
    Common variants on 17q25 and gene-gene interactions conferring risk of schizophrenia in Han Chinese population and regulating gene expressions in human brain.
    Mol Psychiatry. 2016 Jan 5. doi: 10.1038/mp.2015.
    PubMed     Text format     Abstract available


  55. GREEN EK, Rees E, Walters JT, Smith KG, et al
    Copy number variation in bipolar disorder.
    Mol Psychiatry. 2016;21:89-93.
    PubMed     Text format     Abstract available


    December 2015
  56. SELLGREN CM, Kegel ME, Bergen SE, Ekman CJ, et al
    A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.
    Mol Psychiatry. 2015 Dec 15. doi: 10.1038/mp.2015.
    PubMed     Text format     Abstract available


  57. TANSEY KE, Rees E, Linden DE, Ripke S, et al
    Common alleles contribute to schizophrenia in CNV carriers.
    Mol Psychiatry. 2015 Dec 8. doi: 10.1038/mp.2015.
    PubMed     Text format    


    June 2015
  58. KULKARNI J, Gavrilidis E, Wang W, Worsley R, et al
    Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age.
    Mol Psychiatry. 2015;20:695-702.
    PubMed     Text format     Abstract available


    March 2015
  59. BRENNAND K, Savas JN, Kim Y, Tran N, et al
    Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia.
    Mol Psychiatry. 2015;20:361-8.
    PubMed     Text format     Abstract available


    February 2015
  60. FRANK J, Lang M, Witt SH, Strohmaier J, et al
    Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients.
    Mol Psychiatry. 2015;20:150-1.
    PubMed     Text format    


  61. ANDREASSEN OA, Harbo HF, Wang Y, Thompson WK, et al
    Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.
    Mol Psychiatry. 2015;20:207-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: